Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford OX37LE, UK.
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2486-2499. doi: 10.1210/clinem/dgad205.
Klinefelter syndrome is the most common chromosomal disorder in males and the most common cause of hypergonadotropic hypogonadism. We describe the natural history of testicular dysfunction in patients with Klinefelter syndrome through the integration of clinical, hormonal, and quantitative ultrasound data in a life-course perspective.
Prospective semilongitudinal study.
We included 155 subjects with 47,XXY karyotype (age range: 7 months-55 years) naïve to testosterone replacement therapy. Subjects were divided according to pubertal stage and age group (transition age and adults). Serial clinical, hormonal, and testicular ultrasound (US) assessments were performed.
Testicular development progresses until Tanner stage 4, with subsequent regression, whereas Sertoli and germ cell impairment is not hormonally detected before Tanner stages 3-4, as reflected by normal inhibin B values until stage 4 and the fall in the inhibin B/follicle-stimulating hormone ratio thereafter. The testosterone/luteinizing hormone ratio peaks during Tanner stages 2-3 and declines from Tanner stage 4 onward, preceding the development of overt hypogonadism. US echotexture progressively worsens until transition age, reflecting ongoing gonadal compromise, whereas quantitative US echotexture measures and the presence of both hypoechoic lesions and microlithiasis independently and significantly predict a lower circulating testosterone level.
The findings from this large prospective study contribute to our understanding of the natural history of testicular dysfunction in Klinefelter syndrome, underlining the importance of quantitative testicular US in infancy and childhood, as well as during pubertal development and transition age, for the optimal care of Klinefelter syndrome patients.
克氏综合征是男性最常见的染色体疾病,也是促性腺激素性性腺功能减退症最常见的原因。我们通过整合临床、激素和定量超声数据,从生命过程的角度描述克氏综合征患者睾丸功能障碍的自然史。
前瞻性半纵向研究。
我们纳入了 155 名 47,XXY 核型(年龄范围:7 个月至 55 岁)的患者,这些患者均未接受过睾酮替代治疗。根据青春期阶段和年龄组(青春期过渡期和成人期)对患者进行分组。对患者进行了连续的临床、激素和睾丸超声(US)评估。
睾丸发育一直持续到 Tanner 分期 4 期,随后出现退化,而在 Tanner 分期 3-4 期之前,Sertoli 和生殖细胞的损伤并未在激素水平上被检测到,这反映在正常的抑制素 B 值直到分期 4 期,以及此后抑制素 B/卵泡刺激素比值的下降。睾酮/黄体生成素比值在 Tanner 分期 2-3 期达到峰值,然后从 Tanner 分期 4 期开始下降,先于明显性腺功能减退的发生。US 回声纹理在青春期过渡期之前一直逐渐恶化,反映了持续的性腺损伤,而定量 US 回声纹理测量值以及低回声病变和微结石的存在均独立且显著地预测了循环睾酮水平较低。
这项大型前瞻性研究的结果有助于我们了解克氏综合征患者睾丸功能障碍的自然史,强调了定量睾丸 US 在婴儿期和儿童期、青春期和青春期过渡期的重要性,这对于克氏综合征患者的最佳治疗至关重要。